Administration of ghrelin associated with decreased expression of matrix metalloproteinase-9 following normobaric systemic hypoxia in the brain

Andrews ZB. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci 34, 31–40, 2011.10.1016/j.tins.2010.10.00121035199Open DOISearch in Google Scholar

Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21, 7724–7732, 2001.10.1523/JNEUROSCI.21-19-07724.2001Open DOISearch in Google Scholar

Babri S, Mohaddes G, Alipour MR, Ebrahimi H, Hossenzadeh F. Effects of ghrelin on plasma glucose levels, body weight, food intake and hematocrit in acute and chronic systemic hypoxia in adult male rats. Iran J Endocrinol Metab 15, 100–106, 2013.Search in Google Scholar

Bansal V. Ryu SY, Blow C, Costantini T, Loomis W, Elicerri B, Baird A, Wolf P, Coimbra R. The hormone ghrelin prevents traumatic brain injury induced intestinal dysfunction. J Neurotrauma 27, 2255–2260, 2010.10.1089/neu.2010.1372Open DOISearch in Google Scholar

Bauer AT, Burgers HF, Rabie T, Marti HH. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30, 837–848, 2010.10.1038/jcbfm.2009.248Search in Google Scholar

Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63, 5224–5229, 2003.Search in Google Scholar

Bond M, Chase A, Baker AH, Newby AC. Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50, 556–565, 2001.10.1016/S0008-6363(01)00220-6Search in Google Scholar

Brywe KG, Leverin AL, Gustavsson M, Mallard C, Granata R, Destefanis S, Volante M, Hagberg H, Ghigo E, Isgaard J. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3 beta phosphorylation. Endocrinology 146, 4665–4672, 2005.10.1210/en.2005-0389Search in Google Scholar

Carlini VP, Monzon ME, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 299, 739–743, 2002.10.1016/S0006-291X(02)02740-7Search in Google Scholar

Cheyuo C, Wu R, Zhou M, Jacob A, Coppa G, Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 35, 258–265, 2011.2072051210.1097/SHK.0b013e3181f48a3720720512Search in Google Scholar

Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 148, 148–159, 2007.10.1210/en.2006-09911705302417053024Open DOISearch in Google Scholar

Chung H, Seo S, Moon M, Park S. Phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J Endocrinol 198, 511–521, 2008.10.1677/JOE-08-016018541646Search in Google Scholar

Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50, 329–339, 2005.1584680210.1002/glia.2016915846802Search in Google Scholar

Diano S, Farr SS, Benoit SC, McNay EC, Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks MA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschop MH, Horvath TL. Ghrelin controls hippo-campal spine synapse density and memory performance. Nat Neurosci 9, 381–388, 2006.10.1038/nn165616491079Open DOISearch in Google Scholar

Duansak N, Schmid-Schonbein GW. The oxygen free radicals control MMP-9 and transcription factors expression in the spontaneously hypertensive rat. Microvasc Res 90, 154–161, 2013.10.1016/j.mvr.2013.09.00324060804464299824060804Open DOISearch in Google Scholar

Duran-Vilaregut J, del Valle J, Manich G, Camins A, Pallas M, Vilaplana J, Pelegri C. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington’s disease. Neuropathol Appl Neurobiol 37, 525–537, 2011.10.1111/j.1365-2990.2010.01157.x21175737Search in Google Scholar

Ersahin M, Toklu HZ, Erzik C, Cetinel S, Akakin D, Velioglu-Ogunc A, Tetik S, Ozdemir ZN, Sener G, Yegen BC. The antiinflammatory and neuroprotective effects of ghrelin in subarachnoid hemorrhage-induced oxidative brain damage in rats. J Neurotrauma 27, 1143–1155, 2010.10.1089/neu.2009.121020205513Open DOISearch in Google Scholar

Feizi H, Rajaee K, Keyhanmanesh R, Aliparasti MR, Almasi S, Alipour MR. Effect of ghrelin on renal erythropoietin production in chronic hypoxic rats. Endocr Regul 48, 3–8, 2014.2452437010.4149/endo_2014_01_324524370Search in Google Scholar

Fry M, Ferguson AV. Ghrelin: central nervous system sites of action in regulation of energy balance. Int J Pept 2010, 2010.10.1155/2010/616757292508220798749Search in Google Scholar

Gasche Y, Copin JC, Sugawara T, Fujimura M, Chan PH. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 21, 1393–1400, 2001.10.1097/00004647-200112000-0000311740200Search in Google Scholar

Hossienzadeh F, Babri S, Alipour MR, Ebrahimi H, Mohaddes G. Effect of ghrelin on brain edema induced by acute and chronic systemic hypoxia. Neurosci Lett 534, 47–51, 2013.10.1016/j.neulet.2012.11.06223295905Search in Google Scholar

Higashida T, Kreipke CW, Rafols JA, Peng C, Schafer S, Schafer P, Ding JY, Dornbos D 3rd, Li X, Guthikonda M, Rossi NF, Ding Y. The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury. J Neurosurg 114, 92–101, 2011.10.3171/2010.6.JNS1020720617879Open DOISearch in Google Scholar

Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, Li HT, Wang T. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30, 2286–2291, 2009.10.1016/j.peptides.2009.09.00419747956Open DOISearch in Google Scholar

Kheradmand A, Alirezaei M, Birjandi M. Ghrelin promotes antioxidant enzyme activity and reduces lipid peroxidation in the rat ovary. Regul Pept 162, 84–89, 2010.10.1016/j.regpep.2010.02.008Search in Google Scholar

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660, 1999.10.1038/45230Search in Google Scholar

Lee JY, Choi HY, Na WH, Ju BG, Yune TY. Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury. Biochim Biophys Acta 1842, 2403–2412, 2014.10.1016/j.bbadis.2014.09.006Search in Google Scholar

Liu Y, Wang PS, Xie D, Liu K, Chen L. Ghrelin reduces injury of hippocampal neurons in a rat model of cerebral ischemia/reperfusion. Chin J Physiol 49, 244–250, 2006.Search in Google Scholar

Miao Y, Xia Q, Hou Z, Zheng Y, Pan H, Zhu S. Ghrelin protects cortical neuron against focal ischemia/reperfusion in rats. Biochem Biophys Res Commun 359, 795–800, 2007.10.1016/j.bbrc.2007.05.192Search in Google Scholar

Mohaddes G, Abdolalizadeh J, Babri S, Abedini N, Hossienzadeh F. The anti-edematous effect of ghrelin in brain hypoxia is associated with decreasing expression of vascular endothelial growth factor. J Mol Neurosci 56, 273–277, 2015.2572578610.1007/s12031-015-0528-3Search in Google Scholar

Mohaddes G, Abdolalizadeh J, Babri S, Hossienzadeh F. Ghrelin ameliorates blood-brain barrier disruption during systemic hypoxia. Exp Physiol 102, 376–382, 2017.10.1113/EP086068Open DOISearch in Google Scholar

Park SL, Won SY, Song JH, Kambe T, Nagao M, Kim WJ, Moona SK. EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells. Cell Signal 27, 470–478, 2015.10.1016/j.cellsig.2014.12.001Search in Google Scholar

Reszec J, Hermanowicz A, Rutkowski R, Turek G, Mariak Z, Chyczewski L. Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. Biomed Res Int 2015, 2015.10.1155/2015/646853Search in Google Scholar

Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8, 205–216, 2009.10.1016/S1474-4422(09)70016-XSearch in Google Scholar

Sato T, Ito A, Ogata Y, Nagase H, Mori Y. Tumor necrosis factor alpha (TNFalpha) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1alpha antagonizes the inductive effect of TNF alpha. FEBS Lett 392, 175–178, 1996.10.1016/0014-5793(96)00808-3Search in Google Scholar

Sifringer M, Genz K, Brait D, Brehmer F, Lober R, Weichelt U, Kaindl AM, Gerstner B, Felderhoff-Mueser U. Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Dev Neurosci 31, 394–402, 2009.10.1159/000232557Search in Google Scholar

Vecil GG, Larsen PH, Corley SM, Herx LM, Besson A, Goodyer CG, Yong VW. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res 61, 212–224, 2000.10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9Search in Google Scholar

Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res 83, 832–840, 1998.10.1161/01.RES.83.8.832Search in Google Scholar

Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J Neurosci 20, 7037–7042, 2000.10.1523/JNEUROSCI.20-18-07037.2000Open DOISearch in Google Scholar

Wu H, Dong G, Liu H, Xu B, Li D, Jing H. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression. Eur J Pharmacol 602, 406–412, 2009.10.1016/j.ejphar.2008.11.037Search in Google Scholar

Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27, 697–709, 2007.10.1038/sj.jcbfm.9600375Search in Google Scholar

Zhang Q, Huang C, Meng B, Tang T, Shi Q, Yang H. Acute effect of ghrelin on ischemia/reperfusion injury in the rat spinal cord. Int J Mol Sci 13, 9864–9876, 2012.10.3390/ijms1308986422949835Open DOISearch in Google Scholar

Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494, 528–548, 2006.10.1002/cne.20823Search in Google Scholar